SE460825B - Komposition foer behandling av infektionssjukdomar, gikt och arterioscleros, innehaallande humant pepsin och/eller humant leukocyt-pepsinliknande enzym - Google Patents

Komposition foer behandling av infektionssjukdomar, gikt och arterioscleros, innehaallande humant pepsin och/eller humant leukocyt-pepsinliknande enzym

Info

Publication number
SE460825B
SE460825B SE8306384A SE8306384A SE460825B SE 460825 B SE460825 B SE 460825B SE 8306384 A SE8306384 A SE 8306384A SE 8306384 A SE8306384 A SE 8306384A SE 460825 B SE460825 B SE 460825B
Authority
SE
Sweden
Prior art keywords
human
pepsin
enzyme
human leukocyte
use according
Prior art date
Application number
SE8306384A
Other languages
English (en)
Swedish (sv)
Other versions
SE8306384D0 (sv
SE8306384L (sv
Inventor
H Ohnishi
Original Assignee
Mochida Pharm Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mochida Pharm Co Ltd filed Critical Mochida Pharm Co Ltd
Publication of SE8306384D0 publication Critical patent/SE8306384D0/xx
Publication of SE8306384L publication Critical patent/SE8306384L/
Publication of SE460825B publication Critical patent/SE460825B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/488—Aspartic endopeptidases (3.4.23), e.g. pepsin, chymosin, renin, cathepsin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dispersion Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SE8306384A 1982-11-20 1983-11-18 Komposition foer behandling av infektionssjukdomar, gikt och arterioscleros, innehaallande humant pepsin och/eller humant leukocyt-pepsinliknande enzym SE460825B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP57203990A JPS5995221A (ja) 1982-11-20 1982-11-20 食細胞機能調節作用を有する医薬組成物

Publications (3)

Publication Number Publication Date
SE8306384D0 SE8306384D0 (sv) 1983-11-18
SE8306384L SE8306384L (sv) 1984-05-21
SE460825B true SE460825B (sv) 1989-11-27

Family

ID=16482949

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8306384A SE460825B (sv) 1982-11-20 1983-11-18 Komposition foer behandling av infektionssjukdomar, gikt och arterioscleros, innehaallande humant pepsin och/eller humant leukocyt-pepsinliknande enzym

Country Status (11)

Country Link
US (1) US4534966A (de)
JP (1) JPS5995221A (de)
AU (1) AU552756B2 (de)
CA (1) CA1204054A (de)
CH (1) CH657050A5 (de)
DE (1) DE3341760A1 (de)
FR (1) FR2536281B1 (de)
GB (1) GB2132481B (de)
IT (1) IT1174799B (de)
NL (1) NL8303980A (de)
SE (1) SE460825B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8067531B2 (en) 2004-11-12 2011-11-29 The Zhabilov Trust Inactivated pepsin fragments for modulating immune system activity against human malignant tumor cells
US8309072B2 (en) * 2004-11-12 2012-11-13 The Zhabilov Trust Irreversibly-inactivated pepsinogen fragments for modulating immune function
WO2007041285A2 (en) * 2005-09-29 2007-04-12 Viral Genetics, Inc. Complexes of inactivated pepsin fraction and heat shock protein

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR59346E (fr) * 1949-06-09 1954-05-24 Valise roulante
US2930736A (en) * 1957-01-07 1960-03-29 Nat Drug Co Stabilized trypsin compositions containing partially hydrolyzed gelatin and method of making
FR2119872A1 (fr) * 1970-12-30 1972-08-11 Kuban Med I Im Krasnoi Armii Produit a base de pepsine,notamment pour le traitement des maladies s'accompagnant d'une insuffisance secretoire de l'estomac
US4272522A (en) * 1979-10-15 1981-06-09 Balazs Endre A Method for stimulating phagocytic activity and synergistic compositions therefor
CA1181005A (en) * 1981-02-10 1985-01-15 Haruo Ohnishi Therapeutic agent for treatment of allergic diseases, immune complex diseases and tumors
JPS6238329B1 (de) * 1982-02-09 1987-08-17 Mochida Pharm Co Ltd
WO1983004260A1 (en) * 1982-05-31 1983-12-08 Mochida Pharmaceutical Co., Ltd. Human leukocyte pepsin-like enzyme, and a therapeutic agent containing said enzyme as effective ingredient for treating allergic disorder, immune complex disease, and tumor

Also Published As

Publication number Publication date
DE3341760C2 (de) 1989-09-07
CA1204054A (en) 1986-05-06
GB2132481B (en) 1987-02-11
AU2155483A (en) 1984-05-24
CH657050A5 (de) 1986-08-15
JPH0261925B2 (de) 1990-12-21
GB8330810D0 (en) 1983-12-29
SE8306384D0 (sv) 1983-11-18
JPS5995221A (ja) 1984-06-01
DE3341760A1 (de) 1984-06-14
SE8306384L (sv) 1984-05-21
US4534966A (en) 1985-08-13
FR2536281A1 (fr) 1984-05-25
GB2132481A (en) 1984-07-11
AU552756B2 (en) 1986-06-19
NL8303980A (nl) 1984-06-18
FR2536281B1 (fr) 1989-05-12
IT1174799B (it) 1987-07-01
IT8349367A0 (it) 1983-11-21

Similar Documents

Publication Publication Date Title
LAWLEY et al. Scleroderma, Sjögren-like syndrome, and chronic graft-versus-host disease
JPH07503851A (ja) 改良インターフェロン及びヒトの末梢血液白血球からのその製造方法
JPH10502925A (ja) ラムノリピド類の免疫活性
Neftel et al. Effect of storage of penicillin-G solutions on sensitisation to penicillin-G after intravenous administration
JPH11507914A (ja) Ｍｈｃ−ペプチド複合体の安定な処方物
US20070086993A1 (en) Use of modified lysozyme c to prepare medicinal compositions for the treatment of some serious diseases
US5491150A (en) Supplementary therpeutic agents for the treatment of immunodeficiency syndrome
Nishioka et al. Tuftsin: an immunomodulating peptide hormone and its clinical potential as a natural biological response modifier
US4729893A (en) Enteric encapsulation of ancrod for oral administration
JPH06510908A (ja) 動物ビタミンｄ結合性蛋白からのマクロファージ活性化因子
SE460825B (sv) Komposition foer behandling av infektionssjukdomar, gikt och arterioscleros, innehaallande humant pepsin och/eller humant leukocyt-pepsinliknande enzym
US5151498A (en) Glycoprotein from avena sativa, process for its preparation, and pharmaceutical compositions containing same
JP4006058B2 (ja) 多臓器不全予防及び／又は治療剤
Delespesse et al. Structure, function and clinical relevance of the low affinity receptor for IgE
Oliver et al. Homozygous G6PD deficiency and propacetamol induced hemolysis
AU598817B2 (en) Tumor necrosis factor alpha as treatment for infectious diseases
JP4767382B2 (ja) ＩｇＥ産生抑制剤
JPH029600B2 (de)
Quie Humoral factors in host defense against microbial invaders
WO1983004260A1 (en) Human leukocyte pepsin-like enzyme, and a therapeutic agent containing said enzyme as effective ingredient for treating allergic disorder, immune complex disease, and tumor
EP0891778A2 (de) Mittel für Vorbeugung und/oder Behandlung von strahlungsinduzierter Störungen
JPWO2006085523A1 (ja) 血糖値上昇抑制用組成物
JP4224808B2 (ja) 生理活性物質
JP3056758B2 (ja) グリコシル化インターロイキン‐２含有医薬
JPH11286452A (ja) 病原性細菌及びウイルス感染防御剤

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8306384-2

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8306384-2

Format of ref document f/p: F